2m 2m 2m 2m 2m 2m 2m
Metagenomi Thera (MGX)
NASDAQ
$1.17+$0.005 (+0.43%)
Price as of Sep 11, 2026 7:52 PM EDT- $43.8MMarket Cap
- -37.63%1-Year Change
- BiotechnologyIndustry
Metagenomi Thera (MGX)
$1.17+$0.005 (+0.43%)
MGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.16 | ||
Change | $0.00 (0.00%) | ||
Open | $1.16 | ||
High | $1.22 | ||
Low | $1.16 | ||
Previous Close | $1.16 | ||
Volume | 54,298 | ||
30-Day Average Volume | 162,897 | ||
1-Week Change | -0.85% | ||
1-Month Change | -4.13% | ||
1-Year Change | -37.63% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.8M | ||
Total Assets | $173.7M | ||
Market Cap | $43.8M | ||
Enterprise Value | $4.8M | ||
Period: QTR TTM FY | |||
Revenue | $80.0M | ||
Net Income | -$27.5M | ||
Free Cash Flow | -$19.6M | ||
EBIT | -$27.5M | ||
EBITDA | -$26.2M | ||
Net Working Capital | $96.8M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue